Skip to main content

Personal care materials from CO2

Skin care giant Beiersdorf and Evonik have agreed a research partnership to develop sustainable raw materials for personal care products via artificial photosynthesis, using CO2 as the starting material, along with water, solar energy and bacteria. The two companies described this part of their ongoing efforts to reduce their carbon footprints and becoming carbon-positive.  

Evonik expands in pharma in Germany

Evonik, which is one of the world’s largest pharmaceutical CDMOs, has announced the €25 million first stage of a long-term programme to expand API and advanced intermediates capacity at its sites in Dossenheim and Hanau, Germany. This should be completed by mid-2021 and the whole project should be finalised prior to 2024.

Evonik acquires InnoHealth

Evonik has acquired Spain’s InnovativeHealth Group (InnoHealth) on undisclosed terms and incorporated it into the Care Solutions business line.

Evonik closes PeroxyChem buy

Evonik has closed the $640 million acquisition of PeroxyChem from One Equity Partners, after a lawsuit to block it filed by the Federal Trade Commission in August 2019 was rejected.

ROMEO, ROMEO...

Evonik and nine partners in the ROMEO (Reactor Optimisation by Membrane-Enhanced Operation) project have succeeded in developing catalysing oxo reactions, in which olefins are converted into aldehydes with synthesis gas in a hydroformylation reaction.

Rheticus: Evonik and Siemens launch phase II

Evonik and Siemens have launched their joint research project Rheticus II, which seeks to develop an efficient and powerful test plant that will develop speciality chemicals from CO2, water, renewable electricity and bacteria.
Subscribe to Evonik

 

 

 

AMRI banner advert